BioPharma

07 October, 2026 | Wednesday | News

Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand Identity

Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers navigating increasingly demanding development and manufacturing challenges Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma")...

Lab

09 October, 2026 | Friday | News

Resonant Clinical Solutions and Haier Biomedical Launch Eco-Friendly Centrifuge for Clinical Trials

Resonant Clinical Solutions – a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycle – and Haier Biomedical – a trusted l...

BioTech

12 October, 2026 | Monday | News

Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bi...

Contract Services

05 October, 2026 | Monday | News

Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturing expertise. Integrated approach brings manufactur...

Consumer Health

09 October, 2026 | Friday | Analysis

Semaglutide Generics, Six Months In: Every Launch in India, Every Price, and Where China Stands

AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials from Natco and Eris 3x the premium Natco and Eri...

Medtech

12 October, 2026 | Monday | News

RingConn Smart Ring Secures US FDA 510(k) Clearance for Non-Invasive Blood Oxygen Monitoring

Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (...

Cell & Gene

09 October, 2026 | Friday | News

CellFiber Launches Zeito™ Cell Fibre Fabrication Systems in Japan and US to Advance Cell Therapy Manufacturing

CellFiber, a biotechnology company specialising in cell and gene therapy technologies, has announced the official launch of its Zeito™ series of cell fibre fabrication systems in Japan and the United Stat...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close